Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles.
Aditi MehtaElena Dalle VedoveLorenz IsertOlivia M MerkelPublished in: Pharmaceutical research (2019)
BSA nanoparticles loaded with mutant specific siRNA are a promising therapeutic approach for KRAS-mutant cancers.